patients with type 2 diabetes requiring enhanced glycemic control
''It wasn't really having an effect, but also the cost was a factor because there were other ingredients in the formulation that from a fat-reduction perspective were more effective,'' says Phosphagenics' chief scientific officer, Paul Gavin
"Many GLP1 users report temporary hair shedding, which is translating into increased demand for athome growth treatments, scalp serums, and supplements." The hit to a GLP-1 user's self-confidence from the hair loss can mean even more stress, according to Woolery-Lloyd
Patients with coexisting diabetes or obesity and Crohn's disease require careful coordination between specialists, as GLP-1 agonists' gastrointestinal side effects overlap significantly with IBD symptoms, potentially complicating disease monitoring and management
Many cases of apparent treatment failure turn out to be dosing errors
Improved wound healing, reduced inflammation, reduced hepatic fat content, decreased infarct size following myocardial infarction or intracranial stroke, improved vascular function with decreased oxidative stress, improved endothelial dysfunction, and lowering of albuminuria have also been observed in pre-clinical studies [24]
